Eric Shaff

Eric Shaff is the current President & CEO at Seres Therapeutics. Eric has also previously worked as Vice President, Corporate Finance at Momenta Pharmaceuticals and as Vice President, Finance at Genzyme Corporation. Most recently, they were Senior Analyst at Broadview Int'l (now Jefferies Broadview).

Eric Shaff has a MBA in Finance from Cornell Johnson Graduate School of Management and a BA in Economics and Political Science from the University of Pennsylvania. Eric also attended Belmont Hill for high school.

Kristin Ainsworth - SVP, Corporate Communications, Thomas J. Desrosier - EVP, Chief Legal Officer & Secretary, and David Ege - EVP, CTO report to Eric Shaff.